COLLEEN RUSSELL: Open Payments
NPI 1053192104 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,697 in 250 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $493 · 2025 $3,697
Food & beverage: $3,579Education: $118
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 47 | $636 |
| Teva Pharmaceuticals USA, Inc. | 22 | $517 |
| ABBVIE INC. | 29 | $386 |
| Vanda Pharmaceuticals Inc. | 32 | $378 |
| Axsome Therapeutics, Inc. | 17 | $248 |
| Lundbeck LLC | 14 | $247 |
| Alkermes, Inc. | 15 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $215 |
| Neurocrine BioSciences, Inc. | 14 | $202 |
| Janssen Pharmaceuticals, Inc | 16 | $191 |
Products named: REXULTI, VRAYLAR, HETLIOZ, Auvelity, AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA, INGREZZA.
Industry payments across OH — which companies pay providers there.
